• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region
Dermatology

ADVENT Dermatology Symposium in Denver, CO, USA

This 2-hour educational program delves into the pivotal role of type 2 inflammation in diverse skin conditions, including atopic dermatitis, prurigo nodularis, bullous pemphigoid, and chronic spontaneous urticaria. It will highlight both shared and distinct disease mechanisms and patient burdens, providing crucial insights for optimizing clinical management strategies. Experts will guide the audience through diverse patient cases to illuminate diagnostic nuances and the pathophysiology of each condition. These cases will also highlight the importance of shared decision-making and the broadening of treatment goals beyond symptom control. Dynamic panel discussion and active audience participation will be facilitated through real-time polling and curated Q&A sessions.
Lawrence F. Eichenfield
Sarina Elmariah
Donna Aline Culton
MD
Lawrence F. Eichenfield +3 more
Remind me
ADVENT Dermatology Symposium in Denver, CO
29Mar2026
Begins in
37days
2hours
Location
Embassy Suites by Hilton Denver Downtown Convention Center, Cripple Creek Ballroom, 3rd Floor
1420 Stout St Denver, CO, 80202 United States

Symposium Details

March 28

Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation​

This 2-hour educational program delves into the pivotal role of type 2 inflammation in diverse skin conditions, including atopic dermatitis, prurigo nodularis, bullous pemphigoid, and chronic spontaneous urticaria. It will highlight both shared and distinct disease mechanisms and patient burdens, providing crucial insights for optimizing clinical management strategies. Experts will guide the audience through diverse patient cases to illuminate diagnostic nuances and the pathophysiology of each condition. These cases will also highlight the importance of shared decision-making and the broadening of treatment goals beyond symptom control. Dynamic panel discussion and active audience participation will be facilitated through real-time polling and curated Q&A sessions.

Agenda

Welcome and Introduction
Lawrence Eichenfield
Decoding the Clinical Puzzle: Navigating Diagnostic Complexity Across Inflammatory Skin Diseases
Sarina Elmariah
Shared and Distinct: The Role of Type 2 Inflammation in Skin Diseases
Donna Culton
Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention
Jason Hawkes
Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
Lawrence Eichenfield
Key Takeaways and Audience Q&A
All speakers
Thank You and Closing
Lawrence Eichenfield

Learning objectives

  • Appreciate the variability in clinical presentations across skin diseases with type 2 inflammation
  • Understand the role of type 2 inflammation in pathophysiology to guide treatment decisions
  • Recognize the impact of uncontrolled disease on patients' lives and outline evidence-based management strategies
  • Explore broadening treatment goals beyond symptom control

Location

Embassy Suites by Hilton Denver Downtown Convention Center, Cripple Creek Ballroom, 3rd Floor
1420 Stout St Denver, CO, 80202 United States
Tags
symposium
MAT-GLB-2600618 - 1.0 - 02/2026

Speakers

Dermatology
MD

Lawrence F. Eichenfield

Vice Chair of the Department of Dermatology | University of California San Diego (UCSD) School of Medicine; Chief of Pediatric and Adolescent Dermatology | Rady Children’s Hospital San Diego, California, United States

Dermatology
MD, PhD, MPH

Sarina Elmariah

Associate Professor and Dermatology Director at the UCSF Centre for Itch and Neurosensory Disorders at the University of California in San Francisco, California, US

Dermatology
MD, PhD

Donna Aline Culton

Professor of Dermatology Associate Director, Clinical Trials Unit Director, Clinical Immunofluorescence Laboratory  University of North Carolina, Chapel Hill Chapel Hill, NC, USA

Dermatology
MD, MS

Jason Hawkes

Dr. Hawkes is a board-certified dermatologist and Investigator at the Oregon Medical Research Center in Portland, OR and is a current Councilor in the International Psoriasis Council and serves on the NPF Medical Board and Scientific Advisory Committee